Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tjalling Bosse

Showing results (81-90 of 167) with videos related to

Pageof 17
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 3, 2016
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesSarah Kitson, Vanitha N Sivalingam, James Bolton, et al.
Oncotarget|May 24, 2016
Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancerEllen Stelloo, Marco A Versluis, Hans W Nijman, et al.
Gynecologic Oncology|December 17, 2020
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell linesAnthony N Karnezis, Shary Yuting Chen, Christine Chow, et al.
Histopathology|June 4, 2019
Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancerElke E M Peters, Carla Bartosch, W Glenn McCluggage, et al.
The American Journal of Surgical Pathology|May 23, 2024
Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous ComponentsPhoebe M Hammer, Aihui Wang, Lisa Vermij, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2020
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation statusBasile Tessier-Cloutier, Kim E Kortekaas, Emily Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
The American Journal of Surgical Pathology|April 3, 2026
GLI1-Rearranged Tumors of the gynaecologic Tract: A Detailed Clinicopathologic Study of 10 CasesRoman E Zyla, Brooke E Howitt, Tjalling Bosse, et al.
Gynecologic Oncology|April 23, 2025
Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancerAlicia León-Castillo, Nanda Horeweg, Elke E M Peters, et al.
Pageof 17

Showing results (81-90 of 167) with videos related to

Sort By:
Pageof 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 3, 2016
Ki-67 in endometrial cancer: scoring optimization and prognostic relevance for window studiesSarah Kitson, Vanitha N Sivalingam, James Bolton, et al.
Oncotarget|May 24, 2016
Microsatellite instability derived JAK1 frameshift mutations are associated with tumor immune evasion in endometrioid endometrial cancerEllen Stelloo, Marco A Versluis, Hans W Nijman, et al.
Gynecologic Oncology|December 17, 2020
Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell linesAnthony N Karnezis, Shary Yuting Chen, Christine Chow, et al.
Histopathology|June 4, 2019
Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancerElke E M Peters, Carla Bartosch, W Glenn McCluggage, et al.
The American Journal of Surgical Pathology|May 23, 2024
Molecular Classification Outperforms Histologic Classification in Prognostication of High-grade Endometrial Carcinomas With Undifferentiated and Sarcomatous ComponentsPhoebe M Hammer, Aihui Wang, Lisa Vermij, et al.
Oncoimmunology|March 28, 2017
Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibitionFlorine A Eggink, Inge C Van Gool, Alexandra Leary, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 24, 2020
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation statusBasile Tessier-Cloutier, Kim E Kortekaas, Emily Thompson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2016
Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancerInge C Van Gool, Ellen Stelloo, Remi A Nout, et al.
The American Journal of Surgical Pathology|April 3, 2026
GLI1-Rearranged Tumors of the gynaecologic Tract: A Detailed Clinicopathologic Study of 10 CasesRoman E Zyla, Brooke E Howitt, Tjalling Bosse, et al.
Gynecologic Oncology|April 23, 2025
Pattern of recurrence of the molecular subgroups in stage I high-grade endometrial cancerAlicia León-Castillo, Nanda Horeweg, Elke E M Peters, et al.
Pageof 17